In which Sam, Richard and Gaby talk about the new long-acting injectable PrEP agent, cabotegravir - reviewing efficacy, side effects and how this all fits into a larger landscape of HIV prevention and equity.
Read More
And don’t forget to check us out on Apple Podcasts or Spotify, if that’s more your thing.
In which Sam, Richard and Gaby talk about the new long-acting injectable PrEP agent, cabotegravir - reviewing efficacy, side effects and how this all fits into a larger landscape of HIV prevention and equity.
Read More